Healome Therapeutics has raised £2 million in seed funding to [...]
PhoreMost has unveiled its lead oncology programme, PMC-001, as the [...]
Healome Therapeutics has raised £2 million in seed funding to [...]
PhoreMost has unveiled its lead oncology programme, PMC-001, as the [...]